Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026)

Akebia Therapeutics (AKBA) has 9 years of Debt Ratio data on file, last reported at 0.13 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.13, down 10.06% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.13 (down 10.06% YoY), and the FY2025 annual result was 0.13, down 26.93% from the prior year.
• Debt Ratio rose to 0.13 in Q1 2026 per AKBA's latest filing, from 0.13 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.19 in Q4 2022 and troughed at 0.13 in Q4 2025.
• A 5-year average of 0.16 and a median of 0.17 in 2023 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio increased 22.2% in 2024, then fell 29.34% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.19 in 2022, then dropped by 22.68% to 0.14 in 2023, then advanced by 22.2% to 0.18 in 2024, then retreated by 26.93% to 0.13 in 2025, then rose by 5.25% to 0.13 in 2026.
• Business Quant data shows AKBA's Debt Ratio at 0.13 in Q1 2026, 0.13 in Q4 2025, and 0.13 in Q3 2025.